China Approves First Recombinant Botulinum Toxin for Glabellar Lines
The neurotoxin, developed by Claruvis Pharmaceutical, uses a precision-engineered recombinant manufacturing process for botulinum toxin type A.
Tag: Claruvis Pharmaceutical
All
Popular
All
LatestSorry, No Posts Found
All
Latest
New Skincare System Targets Recovery After Laser and Microneedling Treatments
The professional-exclusive serum and cream use epidermal growth factor and amino acids to support skin barrier repair, with small clinical studies reporting improvements in redness, hydration, and recovery following aesthetic procedures.
